ClinicalTrials.Veeva

Find clinical trials for Acute Myeloid Leukemia (AML) in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Leukemia
Acute Myeloid Leukemia
Myeloid Leukemia
Myelodysplastic Syndromes
Preleukemia
Syndrome
Cancer

Acute Myeloid Leukemia (AML) trials near San Antonio, TX, USA:

A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML) (VIALE-T)

The main objective of this study is to evaluate the efficacy of venetoclax in combination with azacitidine to improve Overall Survival (OS) in Acute...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Cancer
Other: Best Supportive Care (BSC)
Drug: Venetoclax

Phase 3

AbbVie
AbbVie

San Antonio, Texas, United States and 164 other locations

This study enrolled 472 participants, aged 55 or older, with a diagnosis of de novo acute myeloid leukemia (AML) ...

Active, not recruiting
Leukemia, Myeloid, Acute
Drug: Placebo
Drug: Oral Azacitidine

Phase 3

Celgene
Celgene

San Antonio, Texas, United States and 222 other locations

three separate safety run-in cohorts in neuroblastoma, acute myeloid leukemia (AML), and acute lymphobla...

Active, not recruiting
Acute Lymphoblastic Leukemia (ALL)
Acute Myeloid Leukemia (AML)
Drug: Fludarabine
Drug: Idasanutlin

Phase 1, Phase 2

Roche
Roche

San Antonio, Texas, United States and 19 other locations

Locations recently updated

This study is a first-in-human, Phase 1a/1b, multicenter, open-label study to determine the safety, tolerability, and pharmacokinetics of aplitabart...

Enrolling
Chronic Lymphocytic Leukemia
Acute Myeloid Leukemia
Drug: Bevacizumab (and approved biosimilars)
Drug: FOLFIRI

Phase 1

IGM Biosciences

San Antonio, Texas, United States and 57 other locations

Extension study to provide ongoing long-term treatment with ASTX727 for participants who were benefitting from ASTX727 treatment in a previous Astex-...

Invitation-only
Acute Myeloid Leukemia
Chronic Myelomonocytic Leukemia
Drug: ASTX727

Phase 2

Astex Pharmaceuticals
Astex Pharmaceuticals

San Antonio, Texas, United States and 33 other locations

Some people with MDS have a risk of the disease progressing to acute myeloid leukemia (AML), and a risk of death ...

Active, not recruiting
Myelodysplastic Syndrome (MDS)
Drug: Azacitidine
Drug: Venetoclax

Phase 3

AbbVie
AbbVie

San Antonio, Texas, United States and 219 other locations

azacitidine. (An event is defined as death or transformation to AML in participants with MDS or CMML, whichever occurs first, and is defined...

Active, not recruiting
Leukemia, Myeloid, Acute
Leukemia, Myelomonocytic, Chronic
Drug: Pevonedistat
Drug: Azacitidine

Phase 3

Takeda
Takeda

San Antonio, Texas, United States and 241 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems